Power3 Medical Products Inc. (PWRM)

Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease).

The NuroPro Blood Test is Power3 Medical’s diagnostic tool for the early detection of Neurodegenerative diseases. The analysis is designed as a tool for physicians to diagnose various degenerative diseases of the brain and nervous system. The test involves monitoring the concentration of 59 proteins in blood serum to accurately detect and distinguish between Alzheimer’s disease, ALS (Lou Gehrig’s disease), and Parkinson’s disease. Early detection of these diseases will allow physicians to intervene at an early stage to delay disease progression, potentially allowing patients to outlive their debilitating symptoms.
Alzheimer’s disease is a type of brain disorder in which a person fails to follow his daily routine with full attentiveness. This disease usually appears in older people due to some genetic mutations that may cause building up of amyloidal proteins. This disease is less common in youth. If this disease runs into your family then any of the family members can show the symptoms as this disease is also a genetic disease.
Alzheimer’s disease is generally mistreated at early stages, because people and sometimes even doctors do not realize that the common symptoms like forgetfulness and losing track of things, vision problems and problem in hearing can be related to Alzheimer’s disease.

The NuroPro Test is currently in the development stages. The company has completed proof-of-concept and clinical validation studies, with results exceeding expectations. Currently, Power3 Medical has commenced a three hundred patient clinical validation study of its NuroPro diagnostic test for Alzheimer’s disease and Parkinson’s disease.

For more information about Power3 Medical Products, Inc., please visit http://www.power3medical.com

*********************************************

Aurizon Mines Ltd (AMEX:AZK) is pleased to announce that George N. Paspalas has agreed to join the Company as President and Chief Executive Officer and as a member of the Company’s Board of Directors, effective August 15, 2011. David Hall will continue as President & Chief Executive Officer until August 15, 2011 and, following Mr. Paspalas’s appointment, will continue to serve the Company as Chairman of the Board.

Aurizon Mines Ltd. engages in the acquisition, exploration, development, and operation of gold properties in North America.

*********************************************

Pioneer Drilling Co. (AMEX:PDC) announced that it has entered into an amendment and restatement of its existing credit agreement. The amended and restated credit agreement provides the Company with a $250 million, five-year, senior secured revolving credit facility. The amended and restated credit agreement, among other things: extends the maturity date of the credit agreement from August 31, 2012, to June 30, 2016; increases the aggregate amount of commitments under the credit agreement from $225 million to $250 million; improves the pricing terms for borrowings and the commitment fee; and provides the Company with increased flexibility under the financial covenants.

Pioneer Drilling Company, through its subsidiaries, provides contract land drilling services and production services to independent and major oil and gas exploration and production companies in the United States and Colombia.

*********************************************

Polymet Mining Corp. (AMEX:PLM) reported that: It has closed the previously-announced $4 million loan from Iron Range Resources & Rehabilitation Board (”IRRRB”), It has exercised its option to acquire two tracts of land totaling approximately 5,375 acres of forests, wetlands, and lakes with high recreational value that are included as part of the proposed land exchange with the U.S. Forest Service.

PolyMet Mining Corp., together with its subsidiary, Poly Met Mining, Inc., engages in the exploration, development, and acquisition of natural resource properties.

*********************************************

Rentech, Inc. (AMEX:RTK) announced its conference schedule for July 2011. July 26-27, 2011 U.S. Department of Energy Biomass 2011, Replace the Whole Barrel, Supply the Whole Market, National Harbor, MD. Attendees and exhibitors: Dan Cohrs, EVP & Chief Financial Officer and Harold Wright, Senior Vice President & Chief Technology Officer.

Rentech Inc. provides alternative and clean energy solutions; and manufactures and sells nitrogen fertilizer products.

**************************************************************

**************************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB).

VirnetX Holding Corp (AMEX:VHC) announced that at the request of the Alliance for Telecommunications Industry Solutions (ATIS), it has agreed to update its licensing declaration to ATIS under ATIS’ Intellectual Property Rights (IPR) policy. This is in response to VirnetX’s March 14, 2011, Statement of Patent Holder identifying a group of its patents and patent applications that VirnetX believes are or may become essential to certain developing specifications in the 3GPP LTE, SAE project. VirnetX will make available a non-exclusive patent license under FRAND (fair, reasonable and non-discriminatory terms and conditions, with compensation) to 3GPP members desiring to implement the Technical Specifications identified by VirnetX, as set forth in the updated licensing declaration under ATIS’ IPR policy.

VirnetX Holding Corporation engages in developing and commercializing software and technology solutions for securing real-time communications over the Internet.

*********************************************

Power3 Medical Products, Inc (PWRM)

Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease).

Breast cancer (breast) refers to the appearance of a malignant tumor in any part of the mammary gland. It is the second most common cancer in the world.

The growth and spread of breast cancer depends on the type of malignant cells that constitute it. If cancer is detected before it has spread to lymph or other body parts, the possibility of control is 90%, which means staying alive and without tumor five years after treatment.
The main signs and symptoms are:

A breast lump
Change the shape or contour of the breast
Collapse or crushing of the skin
Nipple retraction, or peeling
The breast looks red and swollen

Power3 Medical Products, Inc. applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 Medical has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer’s, Parkinson’s, and ALS diseases, for which it is currently engaged in Phase II clinical trials. These tests are designed to analyze an individual’s proteins to detect the presence of disease, a patient’s disease progression, a patient’s response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.

Power3 Medical Products, Inc is a breakthrough proteomics company specializing in the identification of disease footprints in the areas of chemotherapeutic drug resistance and the early detection of breast cancer and neurological diseases. The research platform is centered on the study of proteomics, the science of protein interactions within living cells. With a combined 50+ years of proteomic experience, the Company has identified 334 protein biomarkers with the following potential medical applications:
Breast Cancer
Alzheimer’s Disease
ALS (Lou Gehrig’s Disease)
Parkinson’s Disease
Chemotherapeutic Drug Resistance
Leukemia
Gastrointestinal Disease
Metabolic Syndrome

For more information about Power3 Medical Products, Inc. please visit http://www.power3medical.com

*********************************************

Midway Gold Corp (AMEX:MDW) announced it has joined the U.S. broad-market Russell 3000® Index upon Russell Investments reconstituting its comprehensive set of U.S. and global equity indexes on June 24. Annual reconstitution of Russell’s U.S. indexes (www.russell.com/indexes) captures and ranks the 4,000 largest U.S. stocks as of the end of May by total market capitalization. Membership in the Russell 3000, which remains in place for one year, means automatic inclusion in the small-cap Russell 2000® Index as well as the appropriate growth and value style indexes. Russell determines membership for its equity indexes primarily by objective, market-capitalization rankings and style attributes.

Midway Gold Corp., an exploration stage company, engages in the acquisition, exploration, and development of mineral properties in North America.

*********************************************

Palatin Technologies Inc. (AMEX:PTN) announced that Alan W. Dunton, M.D., has formally joined Palatin’s Board of Directors as an independent director and member of Palatin’s Audit and Compensation Committees. “Dr. Dunton brings Palatin both substantial drug development experience and clinical research experience,” said Carl Spana, Ph.D., Palatin’s CEO. “He has played a key role in the development of more than 20 products to regulatory approval. We look forward to working with him as a member of our Board of Directors.”

Palatin Technologies, Inc., a biopharmaceutical company, develops peptide, peptide mimetic, and small molecule agonist compounds with a focus on melanocortin and natriuretic peptide receptor systems in the United States.

*********************************************

Quepasa Corp. (AMEX:QPSA) announced preliminary results from the launch of its first proprietary social gaming title, Cidade Maravilhosa - Rio, on Facebook. Quepasa highlighted that Cidade Maravilhosa has achieved over 150,000 installs in its first 10 full days on Facebook, with daily installs growing over 1,100% week over week as of June 28th.

Quepasa Corp., through its Web site, Quepasa.com, operates as an online social community for young Hispanics. Quepasa.com provides users with access to an expansive, multilingual menu of resources that promote social interaction, information sharing, and other topics of importance to Hispanic users.

**************************************************************

**************************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB).

Axcelis Technologies Inc. (Nasdaq:ACLS) announced that a major foundry has selected the IntegraTM ES plasma dry strip system to support their most advanced, high-volume device manufacturing facilities. The systems have started shipping this month to multiple fabs worldwide.

Axcelis Technologies, Inc. designs, manufactures, and services ion implantation, dry strip, and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and the Asia Pacific.

**************************************************

Power3 Medical Products, Inc. (PWRM)

Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease). Power3 Medical Products, Inc. applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 Medical Products, Inc. has developed a portfolio of products including BC-SeraPro, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer’s, Parkinson’s and ALS diseases, for which it is currently engaged in Phase II clinical trials. These tests are designed to analyze an individual’s proteins to detect the presence of disease, a patient’s disease progression, a patient’s response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.

Power3 Medical Products, Inc use NuroPro Blood Test as diagnostic tool for the early detection of Neurodegenerative diseases. The analysis is designed as a tool for physicians to diagnose various degenerative diseases of the brain and nervous system. The test involves monitoring the concentration of 59 proteins in blood serum to accurately detect and distinguish between Alzheimer’s disease, ALS (Lou Gehrig’s disease), and Parkinson’s disease. Early detection of these diseases would allow physicians to intervene at an early stage to delay disease progression, potentially allowing patients to outlive their debilitating symptoms.

Alzheimer’s disease is the most common dementia. Damaged tissue builds up in the brain and forms deposits called ‘plaques’ and ‘tangles’ which cause the cells around them to die. It also affects chemicals in the brain which transmit messages from one cell to another.

Memory and the ability to think clearly are gradually lost over time. There may also be a change in personality. Someone who used to be a calm person may become agitated or upset more easily, for example. Behavior problems and communication difficulties may also occur.

For more information, please visit the website: http://www.power3medical.com.

*************************************

Crown Equity Holdings Inc. (CRWE)

Writing an online newsletter can really help your online business. Great online newsletters are valuable to their readers and they’re even more important to their publisher. There are a lot of benefits for publishing an online newsletter.

The major benefit of publishing an online newsletter is you get the ear of potential customers. As often as you publish that newsletter is as often as you get to sit down with a potential customer. You can tell them anything. But what you should be doing is giving them valuable information so they will see you as someone they should trust. Then they will be much more likely to buy from you.

Crown Equity Holdings Inc., together with its digital network, currently provides electronic media services specializing in online publishing, which brings together targeted audiences and advertisers. Crown Equity Holdings Inc. offers internet media-driven advertising services, which covers and connects a range of marketing specialties, as well as search engine optimization for clients interested in online media awareness.

CRWE’s digital network is designed, on behalf of its clients, to bring together targeted high-income audiences and advertisers on its financial websites that include, among others, DrStockPick.com, PennyOmega.com, BestOtc.com, CRWEFinance.com, CRWESelect.com, CRWEPicks.com and StockHotTips.com.

Crown Equity Holdings Inc. recently announced that it has extended its CRWENEWSWIRE global platform web presence and is now publishing online news and information to the following countries: Argentina, Australia, Brazil, China, France, Germany, India, Ireland, Italy, Japan, Malaysia, Mexico, New Zealand, Russia, Singapore, South Africa, South Korea, Spain, Taiwan, United Arab Emirates and the United Kingdom, using their specific country code domain and native language.

For more information, please visit their website: http://www.crownequityholdings.com

**************************************************

Local.com Corp. (Nasdaq:LOCM) announced the extension and expansion of their strategic distribution agreement with AT&T Interactive. As part of the agreement, AT&T Interactive’s YP.com advertiser listings will be given premier placement on Local.com search results’ pages. The expanded one-year agreement provides for increased collaboration between the companies on new distribution, traffic, product and revenue initiatives.

Local.com Corporation provides local search services on the Internet. It operates Local.com, a local business directory site that provides information on approximately 14 million local businesses.

**************************************************

Microchip Technology Inc. (Nasdaq:MCHP) announced a new series of 16-bit PIC® microcontrollers (MCUs) and dsPIC® Digital Signal Controllers (DSCs) that bring advanced control to cost-sensitive general-purpose and motor-control designs. The new devices enable low-cost, sensorless motor-control designs, with support for a wide range of motor-control algorithms, and include an on-chip Charge Time Measurement Unit (CTMU) and 10-bit Analog-to-Digital Converter (ADC), to enable intelligent sensor applications and mTouch™ capacitive touch sensing. The devices are supported by three new Plug-In Modules (PIMs) and a single-board motor-control starter kit that includes cap-touch sliders and an onboard BLDC motor, making it easy for designers to create high-performance applications in the appliance (e.g. washing machines), medical (e.g. infusion pumps) and industrial (e.g. AC-induction motors) markets, among others.

Microchip Technology Incorporated, together with its subsidiaries, develops, manufactures, and sells semiconductor products for various embedded control applications.

**************************************************************

**************************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB).

National Health Partners, Inc. (NHPR)

Health care costs, and consequently employee health benefits costs, have been increasing at an alarming rate for nearly a decade. Though cost increases had seemed to be leveling out based on 2009 data, cost increases actually jumped in 2010 and are expected to rise further in 2011. Avoiding rising health care costs is nearly impossible, but you can learn about why they continue to rise and what you can do to manage costs for your organization and your employees.

Several factors that have contributed to climbing health care costs over the past decade include:
o Demographics.
o Expansion of health care providers.
o Consolidation of managed care companies.
o Political environment/government regulation.
o Increased utilization and consumer demand.

National Health Partners, Inc. is a national healthcare savings organization that provides discount healthcare membership programs to uninsured and underinsured people through a national healthcare savings network called “CARExpress.”CARExpress is one of the largest networks of hospitals, doctors, dentists, pharmacists and other healthcare providers in the country and is comprised of over 1,000,000 medical professionals that belong to such PPOs as CareMark and Aetna. The company’s primary target customer group is the 47 million Americans who have no health insurance of any kind. The company’s secondary target customer group includes the millions of Americans who lack complete health insurance coverage.

National Health Partners, Inc., a leading provider of discount healthcare membership programs, announced the recent signing of two new significant marketing agreements. These two clients provide very different opportunities and continue to expand the reach of CARExpress into new marketplaces.

By launching their own unique internet marketing program, the first group should be able to provide a widespread push into the on-line market to produce an excellent volume of new CARExpress sales into the pipeline. In addition, the second group offers a reach into the wholesale marketplace where CARExpress will be wrapped into other programs to enhance the value of the overall package to the consumer. They would consider this non-traditional business and a great opportunity to expand their reach as well as recognition of the CARExpress program nationwide.

“Both of these clients will be launching in the next few weeks and we anticipate an excellent response to their campaign rollouts,” stated David M. Daniels, National Health Partners’ President and CEO. “I am very excited about the new opportunities that these two new clients provide to CARExpress. In addition to the new campaign that was launched just a few weeks ago, all of these new client opportunities will offer a sharp increase in CARExpress memberships and have a major impact on our overall sales for 2011.”

The company plans to announce the rollout of these new marketing campaigns as well as several others over the next few weeks.

Please visit its website at www.nationalhealthpartners.com

**************************************************

Morningstar Inc. (Nasdaq:MORN) announced that it plans to report its second-quarter 2011 financial results after the market closes on Wednesday, July 27, 2011. The company does not hold analyst conference calls; however, investors may submit written questions to Morningstar at investors@morningstar.com.

Morningstar, Inc. provides independent investment research to individual investors, financial advisors, and institutional clients worldwide.

**************************************************

Power3 Medical Products, Inc. (PWRM)

Power3 Medical is a leading edge biotechnology company engaged in the early detection, monitoring, and targeting of diseases through the analysis of proteins. This dynamic team utilizes proteomics in the discovery of protein biomarkers, drug pathways, and mechanisms of disease.

Power3 Medical Products, Inc. strives to become the premier biotechnology company specializing in the commercialization of proteomics IP for the diagnosis and treatment of disease by using cutting edge technologies, world class quality procedures and superior research methodologies. The Company will be guided in all of its dealings with its customers, partners, shareholders, associates and investors by the philosophy of best practices.

BC-SeraPro™ is a proteomic test for the diagnosis of breast cancer. This test is designed to measure the quantitative expression level of 22 protein biomarkers in the serum that differentiate between breast cancer patients and control subjects. The level of the biomarkers from the patient’s serum sample is compared to the Power3 Medical Products’ patient database. Statistical analysis by linear discriminant function will analyze the biomarker levels of the patient sample and assign a probability score for the diagnosis of the patient sample. Probability score is ranged from 0.0 to 1.0. Results of the BC-SeraPro™ test should not be considered a standalone diagnosis nor a guarantee and is intended to be used in conjunction with mammography and other accepted modalities.

Breast cancer is often divided into non-invasive and invasive types.
Non-invasive breast cancer: Non-invasive breast cancer is also known as cancer or carcinoma in situ or pre-cancerous cells. This cancer is found in the ducts of the breast and has not developed the ability to spread outside the breast.

Invasive breast cancer: Invasive cancer has the ability to spread outside the breast, although this does not mean it necessarily has spread. The most common form of breast cancer is invasive ductal breast cancer, which develops in the cells that line the breast ducts.

For more information, please visit the website: http://www.power3medical.com

**************************************************

Glu Mobile, Inc. (Nasdaq:GLUU) announced its Gun Bros App is now available with Multiplayer co-op mode for iPad, iPhone and iPod touch. With more than 8 million downloads to date on iOS devices, the Gun Bros Multiplayer update is poised to make shockwaves through the Bros community.

Glu Mobile Inc. engages in the design, marketing, and sale of mobile games worldwide.

**************************************************

Corinthian Colleges Inc. (Nasdaq:COCO) announced a new private education discount loan program with ASFG, LLC (ASFG) for Corinthian students (the “ASFG Program”). ASFG intends to fund approximately $450 million in new student loans over the next two years. Under the ASFG Program, an unaffiliated lender will continue to make private education loans to eligible students and subsequently sell those loans to ASFG or its designee. Under the Company’s existing student loan program, the unaffiliated lender sells the loans to Corinthian.

Corinthian Colleges, Inc. operates as a post-secondary career education company in the United States and Canada.

**************************************************************

**************************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.Crown Equity Holdings Inc. (CRWE.OB) has received 3,000,000 shares of (144) restricted common stock from the company and 3,000,000 shares of free trading shares from a third party (PIERRE BESUCHET) for six months of advertisement services for National Health Partners Inc. (NHPR.OB).
Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB).

VeriFone Systems, Inc. (NYSE:PAY) announced a contract to supply 15,600 NFC/contactless payment solutions to ComfortDelGro Corporation Ltd. for its Singapore taxi fleet. ComfortDelGro is the largest fleet operator in Singapore with 15,600 taxis and is one of the world’s largest land transport companies with a total fleet size of more than 45,600 vehicles. VeriFone’s VX 820 with integrated contactless payment acceptance capability will interface with the in-vehicle Mobile Data Terminals (MDTs) in its entire fleet of taxis.

VeriFone Systems, Inc. designs, markets, and services electronic payment solutions that enable secure electronic payments among consumers, merchants, and financial institutions worldwide.

**************************************************

Power3 Medical Products, Inc. (PWRM)

Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease). Power3 Medical applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 Medical has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer’s, Parkinson’s, and ALS diseases, for which it is currently engaged in Phase II clinical trials. These tests are designed to analyze an individual’s proteins to detect the presence of disease, a patient’s disease progression, a patient’s response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.

The NuroPro Blood Test is Power3 Medical’s diagnostic tool for the early detection of Neurodegenerative diseases. The analysis is designed as a tool for physicians to diagnose various degenerative diseases of the brain and nervous system. The test involves monitoring the concentration of 59 proteins in blood serum to accurately detect and distinguish between Alzheimer’s disease, ALS (Lou Gehrig’s disease), and Parkinson’s disease. Early detection of these diseases will allow physicians to intervene at an early stage to delay disease progression, potentially allowing patients to outlive their debilitating symptoms.

The NuroPro Test is currently in the development stages. The company has completed proof-of-concept and clinical validation studies, with results exceeding expectations. Currently, Power3 has commenced a three hundred patient clinical validation study of its NuroPro diagnostic test for Alzheimer’s disease and Parkinson’s disease.

A chronic, degenerative disease is presenting an enormous public health challenge on a global scale, and it isn’t a new strain of influenza, HIV-AIDS, or TB. It is Alzheimer’s disease. Within the next 30 years, Alzheimer’s is projected to increase from the 35 million affected worldwide today to a staggering 116 million. China alone has 19 million people diagnosed with the disease. This is why the World Economic Forum met in London in January 2010 to evaluate the socio-economic impact of Alzheimer’s on member countries. The projected cost of the disease worldwide in the next three decades is estimated at upwards of $130 billion. According to the 2010 study “Rising Tide: The Impact of Dementia on Canadian Society,” 1 in 11 senior Canadians suffers from Alzheimer’s or other forms of dementia.

For more information, please visit http://www.power3medical.com.

****************************************************

Cleantech Transit Inc (CLNO)

Cleantech Transit Inc. was founded to capitalize on technology advances and manufacturing opportunities in the growing clean energy public transportation sector. Cleantech Transit Inc has expanded its focus to invest directly in specific green projects that could maximize shareholder value. Recognizing the many economic and operational advances of converting wood waste into renewable sources of energy, Cleantech Transit Inc. has selected to invest in Phoenix Energy (www.phoenixenergy.net).

Biomass energy is a relatively clean, renewable energy source involving the use of organic matter which collected energy from the Sun and converted it into chemical energy when it was alive. It is a renewable source as this matter is continually growing and absorbing the Sun’s energy, particularly where biomass crops are farmed. Most biomass energy is sourced from plants which have gathered energy from the Sun through the process of photosynthesis. This form of energy has been used by humans for thousands of years, since humans began to burn wood for heat. Advancements in technology have allowed biomass energy to be used in a wide variety of applications, including liquids and gases used for biofuels to power transport.

Cleantech Transit Inc. is in the business of producing and conserving power. It produces and sells clean electricity globally, with a focus on sustainable energies using renewable resources such as Geothermal, Solar and Wind.

Cleantech Transit, Inc. (CLNO) is pleased to announce it has met its funding requirement to secure the Company’s ability to earn in 25% of the 500KW Merced Project.

The Company is in the final stages of closing its initial interest in the Merced Project and is currently working on completing the necessary documentation and expects closing the transaction soon. As previously announced Cleantech has the option to earn up to 40% of the Merced Project and the Company plans to continue to work towards increasing its interest in the Merced Project as they move ahead.

For more information about CLNO, visit www.cleantechtransitinc.com

**************************************************

ON Semiconductor Corp. (Nasdaq:ONNN), a premier supplier of high performance silicon solutions for energy efficient electronics, and leading Nordic motor supplier Stegia have announced that ON Semiconductor’s AMIS-30624 2-phase stepper motor driver, with built-in position controller and I2C serial interfacing, has been incorporated into Stegia’s stepper motor product line. This enables the creation of highly compact motor systems with next generation functionality.

ON Semiconductor Corporation designs, manufactures, and markets a portfolio of semiconductor components that addresses the design needs of electronic systems and products worldwide.

**************************************************

Cepheid (Nasdaq:CPHD) announced ‘Art Meets Innovation,’ an innovative teaming of Cepheid and Paul Jr. Designs for the unveiling of new Cepheid products at the 2011 American Association of Clinical Chemistry and Clinical Lab Expo, to be held in Atlanta, GA. this July 24-28. At ‘Art Meets Innovation,’ a Cepheid themed project designed and built by Paul Jr. Designs will be unveiled live alongside Cepheid’s new products. The event will take place at 10am on July 26th at Cepheid booth #431.

Cepheid, a molecular diagnostics company, develops, manufactures, and markets integrated systems for testing in the clinical market, as well as for application in legacy biothreat, industrial, and partner markets.

**************************************************************

**************************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB).
Crown Equity Holdings Inc. (CRWE.OB) has received 5,000,000 shares of 144 restricted stocks from the company for 12 months of media advertisement and IR services for Cleantech Transit, Inc. (CLNO.OB).